Choice of replacement therapy for hemophilia-a rebuttal.
Giangrande
P L F
PL
D001779:Blood Coagulation Factors / Q000191:economics / Q000592:standards / Q000627:therapeutic use*; D002951:Citrates; D003451:Cryoprotective Agents; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D006113:United Kingdom
D001779:Blood Coagulation Factors; D002951:Citrates; D003451:Cryoprotective Agents; D011994:Recombinant Proteins